Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study. - Wikidata - wikimedia - TriplyDB

Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study.

Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study.

http://www.wikidata.org/entity/Q34174352

about

REM sleep depotentiates amygdala activity to previous emotional experiences Guidelines for Treating Dissociative Identity Disorder in Adults, Third Revision Pharmacotherapy augmentation strategies in treatment-resistant anxiety disorders Pharmacotherapy for post traumatic stress disorder (PTSD)Stress signalling pathways that impair prefrontal cortex structure and function Pharmacological treatment of PTSD - established and new approaches Control of sleep and wakefulness Neuropsychiatric consequences of cardiovascular medications Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: a systematic review Adrenergic pharmacology and cognition: focus on the prefrontal cortex Catecholamines and cognition after traumatic brain injury Disaster Management: Mental Health Perspective Alpha-2 receptor agonists for the treatment of posttraumatic stress disorder Treatment-refractory anxiety; definition, risk factors, and treatment challenges Patient-reported outcomes in post-traumatic stress disorder. Part II: focus on pharmacological treatment Animal models of post-traumatic stress disorder and recent neurobiological insights.Sleep disturbance in pediatric PTSD: current findings and future directions Psychiatric disorders and sleep Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders Targeting memory processes with drugs to prevent or cure PTSD Pathophysiological links between traumatic brain injury and post-traumatic headaches Targeting Prefrontal Cortical Systems for Drug Development: Potential Therapies for Cognitive Disorders Posttraumatic stress disorder in adults: impact, comorbidity, risk factors, and treatment Assessing Treatment-Resistant Posttraumatic Stress Disorder: The Emory Treatment Resistance Interview for PTSD (E-TRIP)Sleep disturbances, TBI and PTSD: Implications for treatment and recovery Revisiting propranolol and PTSD: Memory erasure or extinction enhancement?The role of norepinephrine in differential response to stress in an animal model of posttraumatic stress disorder.Review of biological mechanisms and pharmacological treatments of comorbid PTSD and substance use disorder.A role for alpha-adrenergic receptors in extinction of conditioned fear and cocaine conditioned place preference Pharmacotherapy of PTSD: premises, principles, and priorities Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder: a placebo-controlled study The long-term costs of traumatic stress: intertwined physical and psychological consequences.The alpha1-adrenergic receptor antagonist, prazosin, reduces alcohol drinking in alcohol-preferring (P) rats.Initiation of pharmacotherapy for post-traumatic stress disorder among veterans from Iraq and Afghanistan: a dimensional, symptom cluster approach Correlates and Treatments of Nightmares in Adults.Combining the α1 -adrenergic receptor antagonist, prazosin, with the β-adrenergic receptor antagonist, propranolol, reduces alcohol drinking more effectively than either drug alone.Interactions between disordered sleep, post-traumatic stress disorder, and substance use disorders In Psychiatric Clinics of North America.Best practice guide for the treatment of nightmare disorder in adults.Tailoring therapeutic strategies for treating posttraumatic stress disorder symptom clusters.

P2860

Q21558655-1630A953-F628-46F0-9E8C-84D8D9A63C6F Q21999074-E610684D-E233-4242-AD25-02A027FCD8F5 Q24243827-64ADA3ED-2FA9-4EB9-8668-B46AD9B556E2 Q24244802-AF9D9540-E027-4D26-8FB4-A2E77B549C64 Q24606025-D38C5DF4-7ACA-4518-99E9-38D1B13DB074 Q24633256-6E6890D7-5A3D-4F3D-B2D1-BFF63B7B6F1B Q24634619-CC3C4DF9-6F9E-4A16-8380-9C0F8C906AF2 Q24635624-469D5848-87DB-4AAE-8C2F-DB0411A9A95A Q24657469-4AC56E1F-F248-4DBC-B95A-77C95766594B Q24684217-01DEBFA4-2E73-42A9-A784-019D21D92AD0 Q26743582-8868732A-EEBA-4B9C-B214-18418ECA4DAD Q26776331-6B02AC5B-084C-44C7-A66A-F629AE90C6C6 Q26795806-7C361B93-6B76-427F-9943-87ACCF8445F9 Q26798229-5061B76E-E5A1-41A5-9CC9-FDF4BB9C517E Q26829332-DB8F8096-F497-43F1-ADAE-0CE2176EF247 Q26864330-EBC70343-5EDA-43F6-90AC-74A2D781B7FB Q26995727-8D789137-B181-45CC-A71C-65A5E3D41409 Q27007685-8A1CA281-1817-499D-B834-A1420D247354 Q27009995-43FE483A-5498-4CD9-A6EE-D138A68BB035 Q27016155-BA096BA1-BED1-4783-85DC-00C0E7E1DC62 Q28067288-9B9E0EFD-8030-4DC9-97E1-0C302B2F8AB2 Q28076907-6E7EF1E8-5D59-4B34-AF37-EE4CD969F433 Q28085335-7C85D6EE-A7C8-4558-9DD5-99B0F5EA0B92 Q28385622-A59FF813-175E-46F8-AB86-909C2ADC1B7D Q28587730-F6F1345F-9862-4533-BD04-B7A79E0B8BCC Q30359967-AE99AABF-AD9C-4A33-8CBC-4116CCB407E3 Q30450972-84C6EAFF-8B66-4DFB-B5CB-FDCE4A70CCB0 Q30458749-4DD7A774-53E0-4AC5-9DFF-88008B812A61 Q30475995-6ED444D3-742B-4881-B530-5F08611B938D Q30479154-72E66E24-E027-4603-B536-49998282F980 Q30481797-BCB5CC8C-23A2-41A3-9A3C-0D749669CD20 Q30483434-B49ECD61-CD21-4D7E-8B75-4D10D813D162 Q30483532-133D8F8E-6CC5-447D-BF48-2C3075141AEB Q30490124-16FBA4E3-4C04-4226-8025-66F6B182262C Q33591296-6A9182CF-2608-4CDA-A164-7C7BFFD25339 Q33719351-FEA4063D-7B44-407D-86C6-B5A9F4DD13F4 Q33736941-3F060E89-48FC-435D-928D-177AFF3E6E48 Q33781739-D9118634-D94B-4694-9210-A1F109351647 Q34058202-EA0F0B88-373F-4E14-974C-4A703845DB84 Q34122994-8C1EAFA0-E9A3-4CE2-88CD-46807DAB7BD8

P2860

Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study.

http://www.wikidata.org/entity/Q34174352

description

2003 nî lūn-bûn

@nan

2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Reduction of nightmares and ot ...... n: a placebo-controlled study.

@ast

Reduction of nightmares and ot ...... n: a placebo-controlled study.

@en

Reduction of nightmares and ot ...... n: a placebo-controlled study.

@nl

type

label

Reduction of nightmares and ot ...... n: a placebo-controlled study.

@ast

Reduction of nightmares and ot ...... n: a placebo-controlled study.

@en

Reduction of nightmares and ot ...... n: a placebo-controlled study.

@nl

prefLabel

Reduction of nightmares and ot ...... n: a placebo-controlled study.

@ast

Reduction of nightmares and ot ...... n: a placebo-controlled study.

@en

Reduction of nightmares and ot ...... n: a placebo-controlled study.

@nl

P1433

Q34174352-58D6FAB0-0B27-4771-A956-C8F2F4DE4E88

P1476

Q34174352-213968E8-095C-4213-9742-B176C324BB20

P2093

Q34174352-1B34F7DB-95AF-40C2-85B5-40A7771DCD79

Q34174352-3A2B9AAA-2A6A-4552-BA28-34A732E35BF0

Q34174352-45AC5772-9765-4EF1-A3DB-566A58A0DBBB

Q34174352-4CBF2970-AA25-4513-A466-122FB25277EE

Q34174352-5906FAD6-E86C-4D9E-A14F-F0843CCF36AE

Q34174352-642F2C54-26B4-467A-9D51-DAC13C26B48C

Q34174352-6AB7474C-374C-4E1C-8549-26A2E34427DA

Q34174352-86D3A6C7-C7F7-46D6-81CB-4FBD17BE3D73

Q34174352-97652D76-8C3D-4DD4-BDBF-9E6B618A7AD2

Q34174352-9F7DAF39-13DA-49F0-9A1B-9B85476CFB2A

P304

Q34174352-AD37B7F8-904C-4EC4-B71B-F8326E4D60B2

P31

Q34174352-C551D79C-0495-4724-A121-243C29CD53F9

P356

Q34174352-1530D686-6D5F-41D0-BD42-FFE8890FA1EA

P407

Q34174352-03B69A40-EB96-4CF6-B6DA-D72805FC4F43

P433

Q34174352-77AB9141-9EBE-45BC-905B-40B67CCD5659

P478

Q34174352-A444F34C-C079-4063-B2AA-9AA2FF096293

P577

Q34174352-816BCFA2-1DB0-4FA4-8F72-6B179391F25C

P5875

Q34174352-DA6A71C1-A591-42F6-AEB7-63612F826109

P698

Q34174352-CDAB20E6-FD8F-4F9F-92C7-383E2D2C51F4

P921

Q34174352-373F794E-AD11-4A9A-850C-3406987A5126

Q34174352-4EABD827-E14E-4EBC-91BC-844215D5D11E

Q34174352-AB03DD24-37B6-4F38-92E7-CD14CACB4CF6

Q34174352-D8700F2C-23F3-495D-AAD1-F3E2C2A32593

Q34174352-E1F85AF9-7169-4478-8038-D96E5E59B45F

P356

APPI.AJP.160.2.371

P1433

American Journal of Psychiatry

P1476

Reduction of nightmares and ot ...... n: a placebo-controlled study.

@en

P2093

Allen Radant

http://www.w3.org/2001/XMLSchema#string

Charles E Thompson

http://www.w3.org/2001/XMLSchema#string

David Hoff

http://www.w3.org/2001/XMLSchema#string

Dorcas J Dobie

http://www.w3.org/2001/XMLSchema#string

Elaine R Peskind

http://www.w3.org/2001/XMLSchema#string

Eric C Petrie

http://www.w3.org/2001/XMLSchema#string

Evan D Kanter

http://www.w3.org/2001/XMLSchema#string

Kristy Straits-Tröster

http://www.w3.org/2001/XMLSchema#string

Miles M McFall

http://www.w3.org/2001/XMLSchema#string

Murray A Raskind

http://www.w3.org/2001/XMLSchema#string

P304

371-373

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1176/APPI.AJP.160.2.371

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

160

http://www.w3.org/2001/XMLSchema#string

P577

2003-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10920772

http://www.w3.org/2001/XMLSchema#string

P698

12562588

http://www.w3.org/2001/XMLSchema#string

P921

post-traumatic stress disorder